Call for Paper
The Journal of Precision Molecular and Clinical Oncology (JPMCO) is currently accepting manuscript submissions for upcoming issues.
As a newly established international peer-reviewed Gold Open Access journal, JPMCO welcomes high-quality research that advances precision oncology, molecular medicine, cancer diagnostics, targeted therapeutics, translational oncology, and related disciplines.
SPECIAL INVITATION TO AUTHORS
Researchers, clinicians, and academic professionals are invited to contribute original research, review articles, case reports, and other scholarly works that support innovation in cancer research and personalized medicine.
OPPORTUNITIES FOR EARLY CONTRIBUTORS
Authors publishing in the journal's initial volumes have the opportunity to contribute to the development of a growing scholarly platform dedicated to advancing precision molecular and clinical oncology research.
INAUGURAL ISSUE PUBLICATION FEE WAIVER
To support the dissemination of high-quality research during the journal's launch phase, JPMCO is pleased to offer a 100% Article Processing Charge (APC) waiver for manuscripts accepted for publication in the inaugural issue.
Authors whose manuscripts are accepted for the inaugural issue will receive full open access publication without any publication fee. This initiative reflects the journal's commitment to encouraging scholarly contributions and fostering the growth of a vibrant research community in precision molecular and clinical oncology.
Authors are encouraged to submit their manuscripts early for consideration in the inaugural issue.
AREAS OF INTEREST
Submissions are encouraged in precision oncology, molecular oncology, cancer genomics, immuno-oncology, translational cancer research, targeted therapies, biomarkers, molecular diagnostics, liquid biopsy, artificial intelligence in oncology, and related fields.
JOIN OUR REVIEWER AND EDITORIAL COMMUNITY
JPMCO also welcomes expressions of interest from qualified researchers and subject experts who wish to contribute as peer reviewers or editorial board members. Scholars with relevant academic, clinical, or research experience are encouraged to contact the Editorial Office for further information.
SUBMISSION AND INQUIRIES
Manuscripts may be submitted through the journal's submission system. Authors are encouraged to review the Instructions for Authors prior to submission.
For manuscript submissions and author inquiries, please contact: submissions@scitxthub.com
For editorial matters, reviewer applications, and editorial board opportunities, please contact: editor@scitxthub.com
JPMCO looks forward to receiving innovative research contributions from the global scientific and clinical community.
